Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease
(Q74428168)
scientific article published on 01 July 2002
scientific article published on 01 July 2002
Language:
Current Data About
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease
other details
description | scientific article published on 01 July 2002 |
External Links
(P356) |
10.1038/SJ.BMT.1703602
|
(P698) |
12105773
|
(P6179) |
1016568882
|